Condition: Tumor, Solid · Tumor · Advanced Solid Tumor · Sponsor: Aadi Bioscience, Inc.
This is a phase 1, multi-center, open-label, dose-escalation study of nab-sirolimus in adult patients with locally advanced or metastatic solid tumors and moderate hepatic impairment or normal hepatic function.
This description comes directly from the study's public registry record.
Aadi Medical Information · 1-888-246-2234 · MedInfo@aadibio.com
Always discuss trial participation with your own doctor first.
| South Texas Accelerated Research Therapeutics, LLC | San Antonio, Texas, United States | Recruiting |
| START Mountain Region | West Valley City, Utah, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05661461